masoprocol has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gnabre, JN; Hsu, MH; Huang, RC; Hwu, JR; Mold, DE; Pao, KC; Unlu, I; Wu, SC | 1 |
| Hsu, CI; Hsu, MH; Huang, RC; Hwu, JR; Lee, YC; Liang, YC | 1 |
2 other study(ies) available for masoprocol and Liver Neoplasms
| Article | Year |
|---|---|
Hepatocellular carcinoma targeting agents: conjugates of nitroimidazoles with trimethyl nordihydroguaiaretic acid.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Masoprocol; Models, Molecular; Molecular Conformation; Nitroimidazoles; Structure-Activity Relationship | 2014 |
Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Galactosides; Glucosides; Glycosylation; Humans; Liver Neoplasms; Masoprocol; Triazoles | 2011 |